8-K: Provectus Biopharmaceuticals Changes Accounting Firms Following Acquisition

Provectus Biopharmaceuticals replaced its independent registered public accounting firm from Marcum LLP to CBIZ CPAs P.C. following CBIZ's acquisition of Marcum's attest business.

Summary

• Provectus Biopharmaceuticals announced a change in its independent registered public accounting firm.
• On November 1, 2024, CBIZ CPAs P.C. (CBIZ) acquired the attest business of Marcum LLP (Marcum).
• As a result, on April 15, 2025, Marcum resigned as the company's independent registered public accounting firm.
• With the approval of the company's Audit Committee, CBIZ was engaged as the company's independent registered public accounting firm on the same date, April 15, 2025.
• The audit report of Marcum for the fiscal years ended December 31, 2024 and 2023 did not contain any adverse opinions, disclaimers, qualifications, or modifications.
• There were no disagreements or reportable events between the company and Marcum during the fiscal years ended December 31, 2024 and 2023, and through April 15, 2025.
• The company did not consult with CBIZ regarding accounting principles or audit opinions prior to the engagement.
• Marcum provided a letter to the SEC agreeing with the company's statements regarding the change in accounting firms.

Sentiment

Score: 7

Explanation: The announcement is neutral, simply stating a change in accounting firms due to an acquisition. There are no indications of financial distress or other negative factors.

Positives

• Marcum's audit reports for the fiscal years 2023 and 2024 were clean, with no adverse opinions or qualifications.
• There were no disagreements or reportable events between Provectus and Marcum during the relevant periods, indicating a smooth transition.

Industry Context

Changes in accounting firms are not uncommon, especially following mergers and acquisitions within the accounting industry. Companies are required to disclose such changes to maintain transparency with investors.

Comparison to Industry Standards

• The process described in the document, including the resignation of the previous auditor and engagement of a new one with Audit Committee approval, is standard practice.
• The disclosure of no disagreements or reportable events is also a typical component of such announcements, aligning with SEC regulations.

Stakeholder Impact

• The change in accounting firm is unlikely to have a significant impact on stakeholders, as it is a routine administrative matter.

Key Dates

Keywords

accounting firm, CBIZ, Marcum, auditor, Provectus Biopharmaceuticals, change of auditor, financial statements, audit committee